Page 22

Farmaceutisch_Tijdschrift_van_Belgie_nr_3_september

Referenties 1 Center for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases, The Pink Book, 13th Edition april 2015. www.cdc.gov/ vaccines/pubs/pinkbook/index.html. 2 Agentschap zorg en gezondheid. Dossier griepvaccinatie 2014. Antwoorden voor professionelen op vragen over griepvaccinatie. www. griepvaccinatie.be. 3 WHO. Influenza (Seasonal). Fact sheet n°211, maart 2014. www.who. int/mediacentre/factsheets/fs211/fr/ 4 Wetenschappelijk instituut volksgezondheid (WIV). Virological Surveillance of Influenza in Belgium. Season 2013-2014. 5 European centre for disease prevention and control (ECDC). Influenza virus characterisation. Surveillance report. Summary Europe, march 2015. http://ecdc. europa.eu/en/publications/_layouts/ forms/Publication_DispForm. aspx?List=4f55ad51-4aed-4d32- b960-af70113dbb90&ID=1295. 6 EBM guideline Influenza. 5-9-2010. Duodecim Medical publications, geraadpleegd via www.ebmpracticenet.be. 7 EBM guideline. De behandeling van griep - richtlijnen voor de patiënt. 23-3-2001.Duodecium Medical publications, geraadpleegd via www.ebmpracticenet.be. 8 World Health Organization. Questions and Answers. Recommended composition of influenza vi-rus vaccines for use in the northern hemisphere 2015-16 influenza season and development of candidate vaccine viruses for pandemic preparedness. 26/02/2015. 9 Federaal kenniscentrum voor de Gezondheidszorg. Vaccinatie tegen seizoensinfluenza: prioritair de kinderen of ander doelgroepen? KCE Report 204As. 2013. https:// kce.fgov.be/publication/report/ seasonal-influenza-vaccinationprioritizing children-or-othertarget groups-part-#.VaOkNIV9JOI. 10 World Health Organization. Recommended composition of influenza virus vaccines for use in the 2015-2016 northern hemisphere influenza season. 26/02/2015. www. who.int/influenza/vaccines/virus/ recommendations/2015_16_north/ en/. 11 European Medicines Agency (EMA)- Committee for Medicinal Products for Human Use. BWP Ad-hoc Influenza working Group. Amended EU recommendations for the seasonal influenza vaccine composition for the season 2015/2016. 21/05/2015. www.ema.europa.eu/ema/index. jsp?curl=pages/news_and_events/ news/2015/05/news_detail_002339. jsp&mid=WC0b01ac058004d5c1. 12 Ambrose C.S. , Levin M.J. The rationale for quadrivalent influenza vaccines. Human vaccines & immunotherapeutics, january 2012, 8(1) : 81-88. 13 Haut conseil de la santé publique (France). Avis relatif à l’utilisation du vaccin contre la grippe saison saisonnière FluarixTetra®. 23 mai 2014. 14 Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI). Twee « tetravalente » influenzavaccins worden aangekondigd voor het influenzaseizoen 2015-2016 : één geinactiveerd (inspuitbaar) vaccin (Alpharix Tetra®) en één levend (intranasaal) vaccin (Fluenz Tetra®). Goed om weten. 21/05/15. www.bcfi.be 15 McKeage K. Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): A review of its use in the prevention of disease caused by Influenza A and B. Drugs (2013) 73 : 1587-1594. 16 Hoge GezondheidsRaad. Advies nr 9211 - Vaccinatie tegen seizoensgebonden griep. Winterseizoen 2014- 2015. 3/09/2014. www.health. belgium.be/internet2Prd/groups/ public/@public/@shc/documents/ ie2divers/19098147.pdf. 17 Centers for Disease Control and Farmaceutisch Tijdschrift voor België – 95ste jaargang n 22 r. 3 - september 2015 Prevention (CDC). Quadrivalent Influenza Vaccine. Questions & Answers. www.cdc.gov/flu/protect/ vaccine/quadrivalent.htm. 18 AstraZeneca. FluenzTMTetra (live attenuated, nasal, influenza vaccine) Scientific dossier Belgium- Luxembourg. 2014. Information provided for educational purposes only. 19 Fleming D.M. et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatric Infectious Disease Journal, oct 2006, 25(10) : 860-869. 20 Belshe R.B. et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med, febr. 2007, 356-7. 21 Ashkenazi S. et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J. 2006 oct, 25(10) : 870-9. 22 JVCI statement on the annual influenza vaccination programme – extension of the programme to children. J. Craig Venter Institute, UK. 25 july 2012. www.gov.uk/ government/uploads/system/uploads/ attachment_data/file/224775/JCVIstatement on-the-annual-influenzavaccination programme-25-July-2012. pdf. 23 Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP) reaffirms recommendation for annual influenza vaccination. 26/02/2015. www.cdc.gov/media/ releases/2015/s0226-acip.html. 24 Centers for Disease Control and Prevention (CDC). Live attenuated influenza vaccine LAIV (The nasal spray flu vaccine) 26/02/2015. www. cdc.gov/flu/about/qa/nasalspray. htm. PraktijkFarmaceutisch Tijdschrift voor België


Farmaceutisch_Tijdschrift_van_Belgie_nr_3_september
To see the actual publication please follow the link above